Synaptogenix Inc

Synaptogenix Inc., a biopharmaceutical company, has made a bold move by investing $100 million in the cryptocurrency TAO, marking a significant departure from its traditional healthcare roots.

Synaptogenix Inc. is a biopharmaceutical company making significant strides in Alzheimer’s treatment and other neurological conditions, offering a beacon of hope for millions of patients worldwide.

Synaptogenix Inc. is a biopharmaceutical company committed to addressing neurological challenges, with a focus on innovative treatments for Alzheimer’s disease and other neurodegenerative conditions.